NorthWest Biotherapeutics Inc (NWBO): Who is Benjamin Tjoa? To me, as I fol...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	18
Posts	346
Boards Moderated	0
Alias Born	04/17/2013

barcode27

Re: None

Monday, 12/30/2019 11:34:25 PM

Monday, December 30, 2019 11:34:25 PM

Who is Benjamin Tjoa?

To me, as I follow every patent-related action that involves the company and DCVax, this question has become more and more important.

I've noticed a trend over the last several years... many of the patents that the company is actively pursuing with the USPTO seem to encounter roadblock after roadblock, with the response from the patent office often being a series of rejections. The reason given 9 times out of 10? Some variation of "Tjoa already did it, this isn't new and patentable material."

Most recent example, a non-final rejection issued to the company on December 19 (for the patent application - OPTIMALLY ACTIVATED DENDRITIC CELLS THAT INDUCE AN IMPROVED OR INCREASED ANTI-TUMOR IMMUNE RESPONSE).

Reason for rejection? You guessed it... Tjoa already did it.

https://drive.google.com/open?id=1uIUUT09G4rug8LdrYKeWEgH1LgAdMdBj

Can someone who's been around here longer than me (more than 5-6 years) shed some light on Tjoa and why the company appears to be headbutting a brick wall here?